Authors


Chad Kessler, MD

Latest:

Risk Stratification for Return Emergency Department Visits Among High-Risk Patients

The authors examined 2 high-risk classification methods to compare and contrast the patient populations, and to identify the preferred method for predicting subsequent emergency department visits.



Kim Brunisholz, MST

Latest:

Physician Assistants and Their Intent to Retire

Physician assistants are increasingly valued in health services access and delivery. Missing from predictive modeling has been the retirement rate.




Amy Holm, MHA

Latest:

Top 10 Ways to Improve Your Physician Quality Reporting System/Group Practice Reporting Option

PQRS and GPRO encompass patient experience, chronic condition management, and population health arenas so that physician reimbursement can be tied to performance. The authors describe how to accurately improve your quality metrics.


Robert E. Burke, MD, MS

Latest:

Use of Postacute Care After Discharge in Urban and Rural Hospitals

Rural patients receive less postacute care after hospital discharge than urban patients, especially after elective joint replacement-a condition selected for bundled payments.



Jonathan Hatoun, MD, MPH, MS

Latest:

Identifying Children at Risk of Asthma Exacerbations: Beyond HEDIS

Analysis of insurance claims reveals that criteria other than the Healthcare Effectiveness Data and Information Set (HEDIS) persistent asthma definition can identify more at-risk patients with reasonable loss of specificity.


Avery C. Plough, BA

Latest:

Does Comparing Cesarean Delivery Rates Influence Women’s Choice of Obstetric Hospital?

This randomized controlled trial finds that a hospital cesarean delivery rate comparison tool affects women’s perceptions but not where they choose to deliver.


Joy Li-Yueh Lee, MS

Latest:

A Systematic Review of Reference Pricing: Implications for US Prescription Drug Spending

Reference pricing is an effective cost-containment tool widely used in other countries; it may be an attractive policy strategy for the US healthcare system.


Jennifer N. Goldstein, MD, MSc

Latest:

Low-Cost Insulin for Socially At-Risk Patients: Evidence for Effectiveness

Human synthetic insulin may offer low-cost, effective treatment for certain patients with diabetes and financial constraints.


Felicia McCant, MSSW

Latest:

Evaluation of a Packaging Approach to Improve Cholesterol Medication Adherence

A 7.6% improvement in 12-month cholesterol refill was observed among US military veterans randomized to an adherence blister packaging intervention versus an education-only intervention.




Ya-Fen Chan, PhD

Latest:

Value-Based Payment in Implementing Evidence-Based Care: The Mental Health Integration Program in Washington State

Value-based payment improved fidelity to key elements of the Collaborative Care Model—an evidence-based mental health intervention—and improved patient depression outcomes in Washington state.




Christian Wernz, PhD

Latest:

Computed Tomography Scan Use Variation: Patient, Hospital, and Geographic Factors

We observed small-area variation in computed tomography scan use for inpatients in New York State, even after controlling for relevant patient and hospital characteristics.


Lisa V. Rubenstein, MD, MSPH

Latest:

Early Changes in VA Medical Home Components and Utilization

Significant changes were found in patients' utilization of healthcare related to early implementation of medical home components in VA primary care clinics.


Mary K. Caffrey
Mary K. Caffrey

Latest:

Healthy State: Practicing What They Preach in Louisiana

An IVBM event cohosted by The American Journal of Managed Care focused on Healthy State, a multiyear, multistakeholder commitment to moving Louisiana ahead in America’s Health Rankings.



Renato G. Martins, MD

Latest:

Second-line and Third-line Chemotherapy for Lung Cancer: Use and Cost

Using health insurance claims, we identified common first-, second-, and third-line chemotherapy regimens for patients with lung cancer and associated utilization and costs of care.


M. Christopher Roebuck, PhD

Latest:

The Price of Progress: Understanding Innovation and Affordability of Prescription Drugs

Economic incentives and patent protections drive development of innovative medications. Drug prices are determined by consumer demand, not production costs. Therefore, governmental regulation risks future investment in research and development.




Jo-Anne Rizzotto, MEd, RD, CDE

Latest:

CHAPTER 3. Guideline for Detection and Management of Diabetes in Pregnancy

From the Adult Diabetes and Clinical Research sections, Joslin Diabetes Center, Harvard Medical School, Boston, Massachusetts


Felicia Forma, BSc

Latest:

The Cost of Adherence Mismeasurement in Serious Mental Illness: A Claims-Based Analysis

This study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo